“全球心臟”力求提供一個論壇，就世界范圍內(nèi)最重要的預(yù)防和控制心血管疾病的問題進(jìn)行對話和教育，特別側(cè)重于中、低收入國家。以預(yù)防為主，寫稿不僅應(yīng)說明問題的范圍或流行病學(xué)，而且應(yīng)說明有效控制和預(yù)防心血管疾病的干預(yù)措施及其前因。重點應(yīng)放在能夠在資源有限的情況下應(yīng)用的方法上。特別歡迎對成功的干預(yù)措施進(jìn)行經(jīng)濟評價。重要的負(fù)面結(jié)果也將被考慮。雖然醫(yī)院或以臨床為基礎(chǔ)的治療的報告不一定會被拒絕，特別是如果這些報告對成本效益高的疾病控制或預(yù)防具有廣泛的影響，但最好是處理以社區(qū)為基礎(chǔ)的活動的報告。鼓勵就心血管監(jiān)測和健康政策、專業(yè)教育、倫理問題和技術(shù)創(chuàng)新，特別是與預(yù)防有關(guān)的技術(shù)創(chuàng)新提交意見。

Global Heart seeks to provide a forum for dialogue and education on matters that relate foremost to the prevention and control of cardiovascular diseases worldwide, with a special focus on countries with middle and lower economies. With the main focus being on prevention, manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent cardiovascular diseases and their antecedent factors. The emphasis should be on approaches that can be applied in settings with limited resources. Economic evaluations of successful interventions will be particularly welcome. Important negative findings will also be considered. While reports of hospital or clinic-based treatments will not necessarily be rejected, particularly if they have broad implications for cost-effective disease control or prevention, manuscripts that address community-based activities will be preferred. Submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations particularly those related to prevention are encouraged.